Top compounds associated with response to DEFB105B


Feature Type Standardized
Nominal ANOVA
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.062 0.05
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.064 0.05
mRNA PF-184 CTRPv2 pan-cancer AAC -0.062 0.06
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.065 0.06
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 0.06
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.06
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
mRNA 968 CTRPv2 pan-cancer AAC -0.13 0.06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
Download CSV